News & Events
27.11.2020 | NMI Reutlingen
Member of the 4D-Bioprinting Network
Since November 2020, the NMI is a partner in the international ZIM network "4D Bioprinting" (FKZ 16KN098801). This network consists of European SMEs and research institutions that are jointly researching innovative bio inks and ...
10.11.2020 | digital
Young scientist wins second prize at Young Scientists Lecture
Kathrin Stadelmann, scientist of the Biomedical Micro and Nano Engineering group at the NMI, won the second prize at the Young Scientists Lecture.
03.7.2020 | Reutlingen
Representative, nationwide corona antibody study starts in Reutlingen
A nationwide antibody study by the Helmholtz Centre for Infection Research (HZI) was launched in the district of Reutlingen at the beginning of July with the aim of gaining a better overview of the occurrence of SARS-CoV-2 infections.
25.6.2020 | Stuttgart
innBW founds association
While the Innovation Alliance Baden-Württemberg, in short innBW, can already look back on a long history, the 13 member institutes joined together to form an association on 24 June.
10.6.2020 | global
CORESMA provides evidence-based data about corona measures
The NMI is collaborating in an international project consortium named CORESMA in which clinical, epidemiological and immunological data will be collected and ...
13.5.2020 | NMI Reutlingen
Corona antibody tests from Reutlingen
The NMI Reutlingen is currently tackling a major problem associated with antibody tests for the detection of COVID-19: false positive test results.
06.5.2020 | NMI Reutlingen
Reprocessing of medical protection masks
NMI supports the University Hospital of Tübingen in clarifying the material Question.
25.3.2020 | NMI Reutlingen
On the track of the coronavirus immune response
As an established research institute, the NMI also focuses on research on infections with the new coronavirus (SARS-CoV-2).
23.3.2020 | Germany/Singapore
One more step towards true precision medicine
Together with Proteona and Synovo, the NMI will use its platform for patient-derived microtumours for drug screening and the discovery of potential drug candidates.
© NMI
The Natural and Medical Sciences Institute (NMI) at the University of Tübingen undertakes applied research and development at the interface of life sciences and material sciences. An interdisciplinary team of scientists opens up and develops new technologies for companies and public research sponsors.
The NMI subsidiary offers customers from the pharmaceutical, biotechnology and medical device industries an integrated portfolio of products and services.
On site in Berlin - In 2015 launched a laboratory at the Bayer CoLaborator.
Investigation of smallest structures, insight into the world of atoms
The Center for Nanoanalysis at the NMI is a regional contact point for innovative companies with material technology issues and product ideas.
Business Areas
